logo

For the Inventor, By the Inventor

Hitchin, United Kingdom

William H Johnson

This inventor holds 24 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignee: Hoffmann-La Roche Inc.. Active years: 1977-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William H Johnson. Retrieved from https://idiyas.com/inventor/william-h-johnson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24

% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 9

Forward Citations = 207(Granted Patents)


Location History:

  • Hitchin, EN (1977 - 1978)
  • Hitchin, GB (1978 - 2001)
  • Bodmin, GB (2001)

Company Filing History:

goldMedal24 out of 5,024 
 
Hoffmann-La Roche Inc.
 patents

Years Active: 1977-2001

Loading Chart...
Areas of Expertise:
Hydroxamic Acid Derivatives
Hydrazine Derivatives
Tumor Necrosis Factor
Metalloproteinase Inhibitors
Amino Acid Derivatives
Phosphinic Acid Derivatives
Peptide Derivatives
Dipeptide Derivatives
Substituted Phenyl Ketones
Benzophenone Glycinamide Derivatives
Joint Disorders
Pharmaceutical Compositions
24 patents (USPTO):Explore Patents
1. 6281363 - Cyclic hydrazine derivatives (2001-08-28),
2. 6265446 - Hydrazine derivatives (2001-07-24),
3. 6239151 - Compounds as inhibitor of tumor necrosis factor alpha release (2001-05-29),
4. 6235787 - Hydrazine derivatives (2001-05-22),
5. 6066662 - Hydroxylamine derivatives and their use as metalloproteinase inhibiting (2000-05-23),
6. 5731441 - Hydroxamic acid derivatives with tricyclic substitution (1998-03-24),
7. 5710167 - Hydroxamic acid derivatives with tricyclic substitution for treating (1998-01-20),
8. 5698690 - Hydroxamic acid derivatives with tricyclic substitution (1997-12-16),
9. 5614625 - Hydroxamic acid derivatives with tricyclic substitution (1997-03-25),
10. 5447929 - Method of treating joint disorders using hydroxamic derivatives (1995-09-05),
11. 5318964 - Hydroxamic derivatives and pharmaceutical compositions (1994-06-07),
12. 5304549 - Amino acid derivatives (1994-04-19),
13. 5006651 - Phosphinic acid derivatives (1991-04-09),
14. 4996358 - Hydroxylamine bearing amino acid derivatives as collagenase inhibitors (1991-02-26),
15. 4885283 - Phosphinic acid derivatives (1989-12-05),

Title: William H. Johnson: Innovator in Hydrazine Derivatives

Introduction

William H. Johnson is a notable inventor based in Hitchin, GB, with a remarkable portfolio of 24 patents to his name. His work primarily focuses on the development of hydrazine derivatives, showcasing his expertise in pharmaceutical innovations aimed at addressing various medical conditions.

Latest Patents

Among his recent contributions to the field, Johnson's patents include a range of cyclic hydrazine derivatives. These derivatives and their pharmaceutically acceptable salts are designed for the treatment of inflammatory and autoimmune diseases, osteoarthritis, respiratory diseases, tumors, cachexia, cardiovascular disease, fever, hemorrhage, and sepsis. This groundbreaking work underscores the therapeutic potential of hydrazine derivatives in modern medicine.

Career Highlights

William H. Johnson is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His tenure at this esteemed organization has provided him with a platform to innovate and contribute significantly to medical research and drug development.

Collaborations

In his career, Johnson has collaborated with esteemed colleagues, including Michael John Broadhurst and Cedric H. Hassall. These partnerships have enhanced his research efforts and contributed to the development of his impactful inventions.

Conclusion

William H. Johnson's contributions to the field of pharmaceuticals through his innovative hydrazine derivatives highlight his importance as an inventor. His dedication to addressing critical health challenges through innovative approaches establishes him as a prominent figure in the realm of medical research and patent development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…